Tianjin Zhong Xin Pharmaceutical Group Corp

Tianjin Zhing Xin Pharma records 1Q21 earnings jump of 25% y-o-y to $44 million - THE EDGE SINGAPORE

Results

Tianjin Zhong Xin Pharma records 1Q21 earnings jump of 25% y-o-y to $44 million

The higher earnings follow increased sales in tandem with China's economic recovery.

SGX query

Tianjin Zhong Xin Pharmaceutical triggers SGX query as shares increase by over 10%

At 11.34am, shares in the company were trading as high as 17.02% up at US$1.10.
Malaysian glove maker UG Healthcare wins for overall sector - THE EDGE SINGAPORE

Billion Dollar Club 2020

Malaysian glove maker UG Healthcare wins for overall sector

UG Healthcare was named the Centurion Club overall sector winner for Healthcare Services

Broker's Calls

'Buy' Tianjin Zhong Xin as TCM demand could rebound strongly: UOB Kay Hian

Despite the impact from the novel coronavirus (Covid-19) lockdown measures, UOB KayHian is still bullish on Tianjin Zhong Xin Pharmaceutical Group Corp.
×